warfarin and Clinical-Deterioration

warfarin has been researched along with Clinical-Deterioration* in 1 studies

Other Studies

1 other study(ies) available for warfarin and Clinical-Deterioration

Article	Year
COVID-19 associated with extensive pulmonary arterial, intracardiac and peripheral arterial thrombosis. BMJ case reports, 2020, Aug-03, Volume: 13, Issue:8 We describe a patient with COVID-19 who developed simultaneous pulmonary, intracardiac and peripheral arterial thrombosis. A 58-year-old man, without major comorbidity, was admitted with a 14-day history of breathlessness. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection was confirmed by laboratory testing. Initial imaging revealed COVID-19 pneumonia but no pulmonary thromboembolism (PTE) on CT pulmonary angiography (CTPA). The patient subsequently developed respiratory failure and left foot ischaemia associated with a rising D-dimer. Repeat CTPA and lower limb CT angiography revealed simultaneous bilateral PTE, biventricular cardiac thrombi and bilateral lower limb arterial occlusions. This case highlights a broad range of vascular sequalae associated with COVID-19 and the fact that these can occur despite a combination of prophylactic and treatment dose anticoagulation. Topics: Anticoagulants; Betacoronavirus; Clinical Deterioration; Computed Tomography Angiography; Coronavirus Infections; COVID-19; Enoxaparin; Heart Diseases; Heart Ventricles; Humans; Male; Middle Aged; Pandemics; Peripheral Arterial Disease; Pneumonia, Viral; Pulmonary Embolism; SARS-CoV-2; Thrombosis; Treatment Outcome; Warfarin	2020

Article

Year

COVID-19 associated with extensive pulmonary arterial, intracardiac and peripheral arterial thrombosis.

BMJ case reports, 2020, Aug-03, Volume: 13, Issue:8

We describe a patient with COVID-19 who developed simultaneous pulmonary, intracardiac and peripheral arterial thrombosis. A 58-year-old man, without major comorbidity, was admitted with a 14-day history of breathlessness. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection was confirmed by laboratory testing. Initial imaging revealed COVID-19 pneumonia but no pulmonary thromboembolism (PTE) on CT pulmonary angiography (CTPA). The patient subsequently developed respiratory failure and left foot ischaemia associated with a rising D-dimer. Repeat CTPA and lower limb CT angiography revealed simultaneous bilateral PTE, biventricular cardiac thrombi and bilateral lower limb arterial occlusions. This case highlights a broad range of vascular sequalae associated with COVID-19 and the fact that these can occur despite a combination of prophylactic and treatment dose anticoagulation.

Topics: Anticoagulants; Betacoronavirus; Clinical Deterioration; Computed Tomography Angiography; Coronavirus Infections; COVID-19; Enoxaparin; Heart Diseases; Heart Ventricles; Humans; Male; Middle Aged; Pandemics; Peripheral Arterial Disease; Pneumonia, Viral; Pulmonary Embolism; SARS-CoV-2; Thrombosis; Treatment Outcome; Warfarin

2020